Division of the National Toxicology Program
The Division of the National Toxicology Program (DNTP) Scientific Director’s Office provides scientific leadership and administrative support for DNTP. The offices supporting the Scientific Director:
- Foster a productive environment for research, testing, and analysis activities
- Promote interactions and coordination among DNTP and NIEHS staff
- Serve as liaison with NIH, other federal agencies, and stakeholders regarding DNTP activities
- Serve as focal point for postdoctoral training opportunities
- Promotes activities intended to increase interactions among DNTP scientific staff including seminars, monthly science forum, and other programs
The Scientific Director provides policy, analytical, and scientific leadership for DNTP as well as planning, managing, and coordinating its internal and external activities. In addition, in a dual-role as Associate Director of the National Toxicology Program (NTP), the Scientific Director manages day-to-day operations and fosters interactions with other federal agencies on NTP activities.
- Brian R. Berridge, D.V.M., Ph.D., D.A.C.V.P.
Scientific Director, Division of the National Toxicology Program
Associate Director, National Toxicology Program
- Tel 984-287-3111
- P.O. Box 12233Mail Drop K2-02Durham, N.C. 27709
Brian Berridge, D.V.M., Ph.D., D.A.C.V.P., joined the NIH in January of 2018 as the Scientific Director of the Division of the National Toxicology Program at the National Institute of Environmental Health Sciences, and the Associate Director of the National Toxicology Program (NTP). Previous to NIEHS, Berridge spent 17 years in the pharmaceutical industry in varying roles as a toxicologic pathologist at Eli Lilly in Indianapolis, Indiana, and GlaxoSmithKline in Research Triangle Park, North Carolina.
Berridge is an Oklahoma State University-trained veterinarian with residency and Ph.D. training from Texas A&M University. He is a Diplomate of the American College of Veterinary Pathologists with post-doctoral training in comparative cardiovascular pathology from the Texas Heart Institute in Houston, Texas. His areas of interest and expertise include toxicologic and comparative pathology with particular interest in cardiovascular and renal pathology. He is a veteran of the U.S. Air Force where he was a non-commissioned officer trained as a histopathology and electron microscopy technologist. Berridge is currently active in various consortium efforts aimed at advancing innovative approaches to modeling human pathobiology that improve the translation of preclinical research to clinical outcomes and advance our ability to characterize human cardiovascular health hazards.
Since joining NIEHS, Berridge has worked to advance public health and toxicology in ways that are translatable, predictive, and timely. He has broadened DNTP’s traditional focus on studying specific chemicals to include analyzing how chemical exposures affect the development of human disease. Initiatives have been introduced to concentrate research and translation efforts in cardiovascular hazard assessment, developmental neurotoxicity, and carcinogenicity testing. These health effects innovations provide opportunity for working across a continuum of knowledge – using contemporary tools such as literature analysis, animal studies, in vitro systems, and in silico or computational analytics – to better understand these diseases and how environmental agents might contribute to them. These efforts complement traditional strategic areas of study within DNTP that are agent-focused and for which DNTP scientists have led research, testing, and literature-analysis activities in support of the NTP since 1978.
Beth M. Perry
Diane L. Spencer, M.S.
Lisa A. Wolf